Let's talk FTE dilutive securities. The Series D & F preferred are no longer outstanding, see footnote 2 of the latest 10Q. There are 2 convertible preferred series outstanding, A & A-1, but they have only about 42K shares of common into which they are convertible, less than 1% of the number of outstanding shares.
A new Series G convertible preferred was issued a few weeks ago but that was issued in exchange for an equal number of shares of common, so that's a wash (i.e. the number of dilutive common shares went up by exactly the same amount that the number of actual common shares outstanding went down).
There is a $12.5M note payable that is convertible at $11.875, but only if the company becomes in default on that note, and they are not in default, so at this point that note payable can't be considered dilutive.
There are some warrants that are in the money but the shares into which such warrants are convertible are not registered, which makes it highly unlikely that such warrants would ever get exercised. If you exercise a warrant when its underlying shares are not registered, you have to wait 6 months before you can sell those shares. Given the volatility in the FTE stock price, it would seem unlikely that anyone would accept the risk of the stock price staying over the warrant exercise price for 6 months after exercise.
So the short answer is, there are no material dilutive securities outstanding for FTE, from a practical perspective.
